CD200 and membrane protein interactions in the control of myeloid cells.: Trends in Immunology

A Neil Barclay; Gavin J Wright; Gary Brooke; Marion H Brown

doi:10.1016/s1471-4906(02)02223-8

CD200 and membrane protein interactions in the control of myeloid cells. Trends in Immunology

A Neil Barclay, Gavin J Wright, Gary Brooke, Marion H Brown

Research output: Contribution to journal › Article › peer-review

Abstract

OX2 (now designated CD200) is a membrane protein expressed by a broad range of cell types. It is the ligand for a receptor restricted to myeloid cells, with the potential to deliver inhibitory signals. This is indicated by the CD200-deficient mouse model, in which myeloid cells are more activated when stimulated immunologically than cells from normal mice. The unusual tissue distribution of CD200 indicates where myeloid cells can be restrictively controlled through cell-cell contact. Recent data on CD200 will be reviewed in the context of other proteins that might have similar roles, in particular, the interaction between CD47 and SIRPalpha (CD172a).

Original language	English
Pages (from-to)	285-290
Number of pages	6
Journal	Trends in Immunology
Volume	23
Issue number	6
DOIs	https://doi.org/10.1016/s1471-4906(02)02223-8
Publication status	Published - 2002

Access to Document

10.1016/s1471-4906(02)02223-8

http://dx.doi.org/10.1016/s1471-4906(02)02223-8

Cite this

@article{8f521b03833e49cdaff309b41bfd99f9,

title = "CD200 and membrane protein interactions in the control of myeloid cells.: Trends in Immunology",

abstract = "OX2 (now designated CD200) is a membrane protein expressed by a broad range of cell types. It is the ligand for a receptor restricted to myeloid cells, with the potential to deliver inhibitory signals. This is indicated by the CD200-deficient mouse model, in which myeloid cells are more activated when stimulated immunologically than cells from normal mice. The unusual tissue distribution of CD200 indicates where myeloid cells can be restrictively controlled through cell-cell contact. Recent data on CD200 will be reviewed in the context of other proteins that might have similar roles, in particular, the interaction between CD47 and SIRPalpha (CD172a).",

author = "Barclay, {A Neil} and Wright, {Gavin J} and Gary Brooke and Brown, {Marion H}",

year = "2002",

doi = "10.1016/s1471-4906(02)02223-8",

language = "English",

volume = "23",

pages = "285--290",

journal = "Trends in Immunology",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - CD200 and membrane protein interactions in the control of myeloid cells.

T2 - Trends in Immunology

AU - Barclay, A Neil

AU - Wright, Gavin J

AU - Brooke, Gary

AU - Brown, Marion H

PY - 2002

Y1 - 2002

N2 - OX2 (now designated CD200) is a membrane protein expressed by a broad range of cell types. It is the ligand for a receptor restricted to myeloid cells, with the potential to deliver inhibitory signals. This is indicated by the CD200-deficient mouse model, in which myeloid cells are more activated when stimulated immunologically than cells from normal mice. The unusual tissue distribution of CD200 indicates where myeloid cells can be restrictively controlled through cell-cell contact. Recent data on CD200 will be reviewed in the context of other proteins that might have similar roles, in particular, the interaction between CD47 and SIRPalpha (CD172a).

AB - OX2 (now designated CD200) is a membrane protein expressed by a broad range of cell types. It is the ligand for a receptor restricted to myeloid cells, with the potential to deliver inhibitory signals. This is indicated by the CD200-deficient mouse model, in which myeloid cells are more activated when stimulated immunologically than cells from normal mice. The unusual tissue distribution of CD200 indicates where myeloid cells can be restrictively controlled through cell-cell contact. Recent data on CD200 will be reviewed in the context of other proteins that might have similar roles, in particular, the interaction between CD47 and SIRPalpha (CD172a).

U2 - 10.1016/s1471-4906(02)02223-8

DO - 10.1016/s1471-4906(02)02223-8

M3 - Article

VL - 23

SP - 285

EP - 290

JO - Trends in Immunology

JF - Trends in Immunology

IS - 6

ER -